Table 4 |
||||||
|
Univariate and multivariate analyses of predictors for administration of a recommended antimalarial (SP, amodiaquine or quinine) |
||||||
|
Univariate model* |
Multivariate model** |
|||||
|
|
||||||
|
Exposure variable |
Crude OR |
95% CI |
P |
Adjusted OR |
95% CI |
P |
|
|
||||||
|
Age group |
||||||
|
Adult (> 12 years) |
1 |
|||||
|
Child (< 5 years) |
1.67 |
0.66–4.26 |
0.280 |
|||
|
Total number of people in household |
0.85 |
0.73–0.99 |
0.041 |
0.79 |
0.64–0.97 |
0.021 |
|
Place of illness recognition |
||||||
|
Home |
1 |
1 |
||||
|
Shamba |
0.19 |
0.07–0.51 |
0.001 |
0.29 |
0.08–1.14 |
0.076 |
|
Diarrhoea or vomiting reported |
||||||
|
No |
1 |
1 |
||||
|
Yes |
5.05 |
1.73–14.74 |
0.003 |
3.24 |
0.85–12.34 |
0.084 |
|
Signs of severe malaria |
||||||
|
No |
||||||
|
Yes |
2.48 |
0.78–7.88 |
0.125 |
3.60 |
0.73–17.86 |
0.117 |
|
Illness label (self-defined) |
||||||
|
Malaria/degedege |
1 |
1 |
||||
|
Homa |
0.10 |
0.04–0.29 |
0.000 |
0.08 |
0.02–0.32 |
< 0.001 |
|
First action: Antipyretic |
||||||
|
No |
1 |
|||||
|
Yes |
0.61 |
0.17–2.23 |
0.451 |
|||
|
First action: Traditional medicine |
||||||
|
No |
1 |
1 |
||||
|
Yes |
0.24 |
0.07–0.81 |
0.022 |
0.08 |
0.01–0.48 |
0.006 |
|
Health facility attendance |
||||||
|
No |
1 |
1 |
||||
|
Yes |
4.46 |
1.69–11.78 |
0.003 |
7.69 |
1.90–31.11 |
0.004 |
|
Antimalarial provider in village1 |
||||||
|
No |
1 |
|||||
|
Yes |
2.10 |
0.67–6.59 |
0.201 |
|||
|
Distance to nearest antimalarial provider (km)***/1 |
0.01 |
0.00–0.43 |
0.017 |
|||
|
Study area |
||||||
|
Ifakara |
1 |
|||||
|
DSS |
0.22 |
0.05–0.98 |
0.046 |
|||
|
|
||||||
|
* 137 observations; ** 136 observations; *** 76 observations (DSS only); 1 Incl. health facilities, drug stores and general shops stocking antimalarials in mid-2004 |
||||||
|
Hetzel et al. BMC Public Health 2008 8:317 doi:10.1186/1471-2458-8-317 |
||||||
